A novel antifungal formula that combines antifungal peptides from Xenorhubdus bacteria with polymers, offering prolonged protection against Candida by enhancing biofilm and controlled release.
This innovative antifungal formula is designed to provide long-lasting protection against Candida infections. By combining antifungal peptides derived from Xenorhubdus bacteria with specialized polymers, this formula enhances biofilm formation on vaginal mucus membranes, offering extended antifungal action. The unique combination aims to improve the efficacy of existing treatments by slowing down the release of active ingredients, thereby maintaining therapeutic levels over an extended period.
Key features:
Applications:
This formula is at Technology Readiness Level 8, indicating it has been tested and validated in relevant environments, including in vivo evaluations using suitable lab animals. This level of readiness suggests that the technology is close to commercial deployment, pending final field trials and regulatory approvals.
The National Research Center of Egypt is a leading scientific organization focused on innovative research across multiple disciplines, including food safety and nanotechnology.